Our mission is to improve the lives of lung transplant patients and their families.

Non-Invasive Testing: A Key to Monitoring Chronic Rejection in Lung Transplantation

Dr. Yuka Furuya, Medical Director for Lung Transplant at CareDx® spoke with Amy Skiba, Executive Director at the Lung Transplant Foundation, and members of the lung transplant community on October 25, 2023, BOS Education Day, about non-invasive testing.

View the recorded video below to learn more about The AlloSure Lung test. This test is intended to assess the probability of allograft rejection in lung transplant recipients with clinical suspicion of rejection and to inform clinical decision-making about the necessity of allograft biopsy in such patients in conjunction with standard-of-care clinical assessment.

related resources

Sign up for updates
Join our community and receive the latest news about lung transplant, including research, inspiring stories, and resources.
Make a donation
Your tax-deductible donation brings us closer to creating a world where all lung transplant patients live long, healthy lives.
The Lung Transplant Foundation is a 501(c)3 non-profit organization.
Provide Website Feedback
Site Design by:
The Design Booth

Disclaimer: This website does not provide medical advice. The information, including but not limited to text, graphics, images, and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment before undertaking any new health care regimen. Never disregard any professional medical advice or delay in seeking care because of something you have read on this website.

Terms of Use